APC CEO Scott Brunner appeared on the Scripps News show “America On The Docket,” talking about the...
As the fallout (and questions) of the official end to the tirzepatide shortage continues, news outlets are continuing to turn to APC for compounders’ perspective. Medscape is the latest, and it quotes CEO Scott Brunner extensively.
APC CEO Scott Brunner appeared on the Scripps News show “America On The Docket,” talking about the...
APC helped push back against the California Board of Pharmacy’s plan to all but outlaw glutathione,...
The Hill covers the fallout from the FDA’s taking tirzepatide off the shortage list — especially...